Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy-Reference-Cited by-同舟云学术

Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy

Published:2019-02-18 Issue:34 Volume:31 Page:1803322
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Adv. Mater.

Author:

Phuengkham Hathaichanok¹,Ren Long¹,Shin Il Woo¹,Lim Yong Taik¹^ORCID

Affiliation:

1. SKKU Advanced Institute of Nanotechnology (SAINT)Department of Nano Engineering, and School of Chemical EngineeringSungkyunkwan University 2066 Seobu‐ro, Jangan‐gu Suwon Gyeonggi‐do 16419 Republic of Korea

Funder

National Research Foundation of Korea

National Research Council of Science and Technology

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.201803322

Reference163 articles.

1. Delivering safer immunotherapies for cancer

2. Cancer immunotherapy comes of age

3. Cancer Immunotherapy

4. Driving CAR T-cells forward

5. CAR T cell immunotherapy for human cancer

Cited by 235 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A natural adhesive-based nanomedicine initiates photothermal-directed in situ immunotherapy with durability and maintenance;Biomaterials;2025-01

2. A dual-enzyme-like photosensitive nanozyme for remodeling the tumor immunosuppressive microenvironment to enhance immunotherapy;Biomaterials;2024-12

3. Mannosylated Fluoropolypeptide Nanovaccines Remodeling Tumor Immunosuppressive Microenvironment to Achieve Highly Potent Cancer Immunotherapy;Advanced Healthcare Materials;2024-09-05

4. Development of a RNA-protein complex based smart drug delivery system for 9-hydroxycamptothecin;International Journal of Biological Macromolecules;2024-09

5. Targeting activation of cGAS-STING signaling pathway by engineered biomaterials for enhancing cancer immunotherapy;Materials Today;2024-09